JZT(SZ:000989) Shang Hai Zheng Quan Bao·2025-04-23 19:54Core Viewpoint - The company reported a significant decline in revenue and net profit for the first quarter, while cash flow from operating activities showed substantial growth [3]. Financial Performance - The company's operating revenue decreased by 25.36% compared to the same period last year, primarily due to a decline in sales of certain products [3]. - The net profit attributable to shareholders decreased by 19.40%, which is mainly attributed to the drop in operating revenue [3]. - The net cash flow from operating activities increased by 118.41%, driven by improved collection of sales receivables and a reduction in cash paid for goods and services [3]. Shareholder Information - The company underwent a change in control, with major shareholder Li Zhenguo transferring 53,500,000 shares (6.25% of total shares) to Heilongjiang Cheneng Venture Capital Co., Ltd. at a price of 7.19 yuan per share, totaling 384,665,000 yuan [6]. - Following the transfer, Cheneng Venture Capital became the controlling shareholder, with the Heilongjiang Provincial Government becoming the actual controller of the company [6]. Share Buyback - The company approved a share buyback plan, allocating between 50 million and 100 million yuan to repurchase shares for employee stock ownership plans or equity incentives [7]. - As of March 17, 2025, the company had repurchased 9,660,000 shares, representing 1.13% of the total share capital, with a total expenditure of approximately 76.2 million yuan [7]. Other Important Matters - The company’s wholly-owned subsidiary transferred 70% of its stake in Beijing Yue Rutang Traditional Chinese Medicine Clinic to Beijing Tenghu Health Technology Co., Ltd., resulting in the clinic no longer being included in the consolidated financial statements [8].